Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Farxiga
Farxiga
Farxiga’s approval for expanded use highlights potential to differentiate in HF space
Clinical Trials Arena
Fri, 05/12/23 - 11:42 am
AstraZeneca
Farxiga
heart failure
Farxiga Approval Expands Use to More Patients With Heart Failure
eMPR
Tue, 05/9/23 - 11:28 pm
AstraZeneca
Farxiga
FDA
Eli Lilly, Boehringer Ingelheim bolster case for Jardiance to treat chronic kidney disease
Fierce Pharma
Sun, 11/6/22 - 01:44 pm
Eli Lilly
Boehringer Ingelheim
chronic kideny disease
Jardiance
Farxiga
AstraZeneca
AstraZeneca’s Farxiga reduces CV mortality risk in Phase III trials
Clinical Trials Arena
Mon, 08/29/22 - 11:01 am
AstraZeneca
Farxiga
clinical trials
heart failure
AZ bites back at rivals with new Farxiga data in heart failure
Pharmaforum
Thu, 05/5/22 - 10:16 am
AstraZeneca
Farxiga
heart failure
clinical trials
Eli Lilly, Boehringer Ingelheim's Jardiance turns up heat on AstraZeneca's Farxiga with broad EU heart failure approval
Fierce Pharma
Mon, 03/7/22 - 10:10 am
Eli Lilly
Boehringer Ingelheim
Jardiance
heart failure
Europe
AstraZeneca
Farxiga
Bayer's Farxiga rival Kerendia scores long-awaited kidney and heart disease nod for Type 2 diabetes patients
Fierce Pharma
Fri, 07/9/21 - 11:58 pm
Bayer
finerenone
Kerendia
kidney disease
heart disease
diabetes
type 2 diabetes
Farxiga
Farxiga faces first heart failure rival as EU OKs Boehringer/Lilly’s Jardiance
Pharmaforum
Wed, 06/23/21 - 10:59 am
AstraZeneca
Farxiga
heart failure
Boehringer Ingelheim
Eli Lilly
Jardiance
ACC 2021: AstraZeneca's Farxiga failed to help COVID-19 patients, but it’s safe for them to use
Fierce Pharma
Sun, 05/16/21 - 11:22 pm
AstraZeneca
Farxiga
COVID-19
Bayer's near-approval Farxiga rival meets goal in 2nd phase 3
Fierce Biotech
Mon, 05/10/21 - 10:03 am
Bayer
finerenone
Farxiga
clinical trials
cardiovascular disease
myocardial infarction
AstraZeneca's big CKD promises come to fruition as Farxiga wins approval in patients regardless of diabetes status
Endpoints
Mon, 05/3/21 - 10:45 am
AstraZeneca
Farxiga
FDA
chronic kidney disease
AstraZeneca's diabetes drug Farxiga nabs coveted kidney disease nod, way ahead of rival Jardiance
Fierce Pharma
Sat, 05/1/21 - 09:23 pm
AstraZeneca
chronic kidney disease
FDA
Farxiga
AstraZeneca’s Farxiga fails phase 3 COVID-19 test
Pharmaforum
Mon, 04/12/21 - 10:33 am
AstraZeneca
diabetes
heart failure
Farxiga
COVID-19
clinical trials
AstraZeneca's Farxiga gets rough FDA review date for groundbreaking move into chronic kidney disease
Endpoints
Wed, 01/6/21 - 11:03 am
AstraZeneca
Farxiga
FDA
chronic kidney disease
Bayer faces an uphill fight with finerenone
EP Vantage
Mon, 10/26/20 - 11:13 am
Bayer
diabetic kidney disease
kidney disease
clinical trials
finerenone
Invokana
Farxiga
The FDA hands Farxiga 'breakthrough' status in CKD, clearing path for AstraZeneca's much-touted therapy
Endpoints
Sun, 10/4/20 - 12:18 am
AstraZeneca
chronic kidney disease
FDA
breakthrough therapy
Farxiga
ESC 2020 – Farxiga impresses in chronic kidney disease
EP Vantage
Mon, 08/31/20 - 10:14 am
ESC
Farxiga
chronic kidney disease
diabetes
clinical trials
AstraZeneca
ESC 2020 – Jardiance joins Farxiga in showing heart failure benefit
EP Vantage
Mon, 08/31/20 - 10:13 am
ESC
Eli Lilly
Boehringer Ingelheim
Farxiga
Jardiance
heart failure
AstraZeneca
After stopping Farxiga trial early, AstraZeneca declares success in CKD treatment
Endpoints
Tue, 07/28/20 - 11:17 am
AstraZeneca
Farxiga
clinical trials
chronic kidney disease
ADA: AstraZeneca's diabetes-fighter Farxiga cuts risk of fast decline in kidney function
Fierce Pharma
Mon, 06/15/20 - 11:10 pm
AstraZeneca
Farxiga
chronic kidney disease
ADA
diabetes
Pages
1
2
3
next ›
last »